Gastrointestinal abnormalities and involvement in systemic mastocytosis

被引:104
作者
Jensen, RT [1 ]
机构
[1] NIDDK, Digest Dis Branch, NIH, Bethesda, MD 20892 USA
关键词
D O I
10.1016/S0889-8588(05)70298-7
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
In 1869, Nettleship and Tay(159) described a 2-year-old child with hyperpigmented, urticarial skin lesions. Their report is credited as being the first description of urticaria pigmentosa. It was not until 1877(54) that mast cells were first described by Ehrlich, who found cells possessing cytoplasmic granules that stained metachromatically with aniline dyes. He called these cells "mastzellen" because they were distended with granules. Subsequently, in 1878, Sangster(191) described a patient with a pigmented, urticarial rash which he called "urticaria pigmentosa." In 1887,(226) Unna demonstrated the presence of mast cells in the skin lesions of affected patients. It was not until 50 years later, in 1933, that Touraine and co-workers(217) suggested that the disease might involve internal organs and 16 years later, in 1949, that Ellis et al(55) established this fact on an autopsy study in a 1-year-old child. In this first description of systemic mastocytosis by Ellis et al(55) the patient had urticaria pigmentosa from birth and developed diarrhea with voluminous, foul-smelling stools. Autopsy revealed hepatomegaly, splenomegaly, and lymphadenopathy, with microscopic infiltration by mast cells of the bone marrow, liver, spleen, lymph node, kidney, and pancreas.(55) Therefore, in both the clinical description and histologically, there was clear evidence for gastrointestinal involvement in the first established case of systemic mastocytosis.(55) In 1936, Sezary(200) proposed the name mastocytosis for this generalized involvement by mast cells.
引用
收藏
页码:579 / +
页数:47
相关论文
共 242 条
[1]   THE EFFECT OF CIMETIDINE AND PROPANTHELINE ON THE SYMPTOMS OF A PATIENT WITH SYSTEMIC MASTOCYTOSIS [J].
ACHORD, JL ;
LANGFORD, H .
AMERICAN JOURNAL OF MEDICINE, 1980, 69 (04) :610-614
[2]   BLEEDING AFTER LIVER-BIOPSY IN A PATIENT WITH SYSTEMIC MASTOCYTOSIS AND MALABSORPTION [J].
ADLER, SN ;
KLEIN, RA ;
LYON, DT .
JOURNAL OF CLINICAL GASTROENTEROLOGY, 1985, 7 (04) :350-353
[3]   DISODIUM-CROMOGLYCATE IN THE TREATMENT OF SYSTEMIC MASTOCYTOSIS INVOLVING ONLY BONE [J].
ALEXANDER, RR .
ACTA HAEMATOLOGICA, 1985, 74 (02) :108-110
[4]  
AMBRUS JL, 1951, GASTROENTEROLOGY, V18, P249
[5]  
AMMANN R, 1972, SCHWEIZ MED WSCHR, V102, P213
[6]   GASTROINTESTINAL INVOLVEMENT IN SYSTEMIC MASTOCYTOSIS [J].
AMMANN, RW ;
VETTER, D ;
DEYHLE, P ;
TSCHEN, H ;
SULSER, H ;
SCHMID, M .
GUT, 1976, 17 (02) :107-112
[7]  
AMMON HV, 1973, GASTROENTEROLOGY, V65, P744
[8]  
[Anonymous], 1869, Br Med J, V2, P323
[9]   DETECTION OF THE MAJOR URINARY METABOLITE OF PROSTAGLANDIN D-2 IN THE CIRCULATION - DEMONSTRATION OF ELEVATED LEVELS IN PATIENTS WITH DISORDERS OF SYSTEMIC MAST-CELL ACTIVATION [J].
AWAD, JA ;
MORROW, JD ;
ROBERTS, LJ .
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 1994, 93 (05) :817-824
[10]   Systemic mastocytosis and other mast cell neoplasms [J].
Bain, BJ .
BRITISH JOURNAL OF HAEMATOLOGY, 1999, 106 (01) :9-17